Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.
暂无分享,去创建一个
A. Santoro | A. Nagler | G. Follows | P. Zinzani | M. Dreyling | B. Childs | F. Hiemeyer | L. Mollica | J. Garcia-Vargas | M. Özcan | P. Panayiotidis | D. Stevens | D. Trevarthen